NCT06388733 2026-04-01A Study Comparing Niraparib With Temozolomide in Adult Participants With Newly-diagnosed, MGMT Unmethylated GlioblastomaNeuroTrials, LLCPhase 3 Recruiting450 enrolled
NCT05700721 2026-02-05Phase II Trial of the PARP Inhibitor Niraparib and PD-1 Inhibitor Dostarlimab in Patients With Advanced Cancers With Active Progressing Brain Metastases (STARLET)M.D. Anderson Cancer CenterPhase 2 Recruiting120 enrolled